Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020141608 - TEST METHOD FOR ULCERATIVE COLITIS AND PRIMARY SCLEROSING CHOLANGITIS

Publication Number WO/2020/141608
Publication Date 09.07.2020
International Application No. PCT/JP2019/051592
International Filing Date 27.12.2019
IPC
G01N 33/53 2006.1
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
C07K 14/705 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
705Receptors; Cell surface antigens; Cell surface determinants
CPC
C07K 14/705
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
705Receptors; Cell surface antigens; Cell surface determinants
G01N 33/53
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
Applicants
  • 国立大学法人京都大学 KYOTO UNIVERSITY [JP]/[JP]
Inventors
  • 塩川 雅広 SHIOKAWA Masahiro
  • ▲桑▼田 威 KUWADA Takeshi
  • 児玉 裕三 KODAMA Yuzo
  • 妹尾 浩 SENO Hiroshi
  • 千葉 勉 CHIBA Tsutomu
Agents
  • 特許業務法人平木国際特許事務所 HIRAKI & ASSOCIATES
Priority Data
2019-00006004.01.2019JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) TEST METHOD FOR ULCERATIVE COLITIS AND PRIMARY SCLEROSING CHOLANGITIS
(FR) MÉTHODE DE TEST POUR LA RECTOCOLITE HÉMORRAGIQUE ET LA CHOLANGITE SCLÉROSANTE PRIMITIVE
(JA) 潰瘍性大腸炎及び原発性硬化性胆管炎の検査方法
Abstract
(EN)
The purpose of the present invention is to provide a test method and the like that is specific for ulcerative colitis and for primary sclerosing cholangitis. The present invention firstly provides a test method for ulcerative colitis, the test method being a detection step of detecting, in a sample and as an indicator of ulcerative colitis, an antibody that immunologically reacts with integrin αVβ6 and/or an antibody that immunologically reacts with integrin αVβ3. The present invention secondly provides a test method for primary sclerosing cholangitis, the test method being a detection step of detecting, in a sample and as an indicator of primary sclerosing cholangitis, an antibody that immunologically reacts with an antibody that immunologically reacts with integrin αVβ6 and/or integrin αVβ3.
(FR)
L'invention concerne une méthode de test et analogue, spécifique de la rectocolite hémorragique et de la cholangite sclérosante primitive. La présente invention concerne tout d'abord une méthode de test pour la rectocolite hémorragique, cette méthode constituant une étape de détection consistant à détecter, dans un échantillon et comme indicateur de la rectocolite hémorragique, un anticorps qui réagit immunologiquement avec l'intégrine αVβ6 et/ou un anticorps qui réagit immunologiquement avec l'intégrine αVβ3. La présente invention concerne d'autre part une méthode de test pour la cholangite sclérosante primitive, cette méthode constituant une étape de détection consistant à détecter, dans un échantillon et comme indicateur de la cholangite sclérosante primitive, un anticorps qui réagit immunologiquement avec un anticorps qui réagit immunologiquement avec l'intégrine αVβ6 et/ou l'intégrine αVβ3.
(JA)
本発明は、潰瘍性大腸炎及び原発性硬化性胆管炎に特異的な検査方法等を提供することを目的とする。 本発明は第一に、潰瘍性大腸炎の検査方法であって、潰瘍性大腸炎の指標として、検体中の、インテグリンαVβ6と免疫学的に反応する抗体、及び/又は、インテグリンαVβ3と免疫学的に反応する抗体を検出する検出工程を提供する。本発明は第二に、原発性硬化性胆管炎の検査方法であって、原発性硬化性胆管炎の指標として、検体中の、インテグリンαVβ6、及び/又は、インテグリンαVβ3と免疫学的に反応する抗体と免疫学的に反応する抗体を検出する検出工程を提供する。
Also published as
JP2020563877
Latest bibliographic data on file with the International Bureau